Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy
- 1 November 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 295 (5) , R1439-R1445
- https://doi.org/10.1152/ajpregu.00736.2007
Abstract
Diabetic cardiomyopathy is characterized by reduced cardiac contractility independent of vascular disease. A contributor to contractile dysfunction in the diabetic heart is impaired sarcoplasmic reticulum function with reduced sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2a) pump activity, leading to disturbed intracellular calcium handling. It is currently unclear whether increasing SERCA2a activity in hearts with existing diabetic cardiomyopathy could still improve calcium flux and contractile performance. To test this hypothesis, we generated a cardiac-specific tetracycline-inducible double transgenic mouse, which allows for doxycycline (DOX)-based inducible SERCA2a expression in which DOX exposure turns on SERCA2a expression. Isolated cardiomyocytes and Langendorff perfused hearts from streptozotocin-induced diabetic mice were studied. Our results show that total SERCA2a protein levels were decreased in the diabetic mice by 60% compared with control. SERCA2a increased above control values in the diabetic mice after DOX. Dysfunctional contractility in the diabetic cardiomyocyte was restored to normal by induction of SERCA2a expression. Calcium transients from diabetic cardiomyocytes showed a delayed rate of diastolic calcium decay of 66%, which was reverted toward normal after SERCA2a expression induced by DOX. Global cardiac function assessed in the diabetic perfused heart showed diminished left ventricular pressure, rate of contraction, and relaxation. These parameters were returned to control values by SERCA2a expression. In conclusion, we have used mice allowing for inducible expression of SERCA2a and could demonstrate that increased expression of SERCA2a leads to improved cardiac function in mice with an already established diabetic cardiomyopathy in absence of detrimental effects.Keywords
This publication has 21 references indexed in Scilit:
- Analysis of cellular calcium fluxes in cardiac muscle to understand calcium homeostasis in the heartCell Calcium, 2007
- Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucoseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transferMolecular Therapy, 2006
- Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Mild irritant prevents ethanol-induced gastric mucosal microcirculatory disturbances through actions of calcitonin gene-related peptide and PGI2in ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Transgenic overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves reticular Ca2+ handling in normal and diabetic rat heartsThe FASEB Journal, 2002
- SERCA Pump Level is a Critical Determinant of Ca2+Homeostasis and Cardiac ContractilityJournal of Molecular and Cellular Cardiology, 2001
- Diminished Expression of Sarcoplasmic Reticulum Ca2+-ATPase and Ryanodine Sensitive Ca2+Channel mRNA in Streptozotocin-induced Diabetic Rat HeartJournal of Molecular and Cellular Cardiology, 2000
- Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation.Journal of Clinical Investigation, 1997
- New type of cardiomyopathy associated with diabetic glomerulosclerosisPublished by Elsevier ,1972